Imaging lung cancer by scintigraphy with indium 111‐labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody F023C5

Abstract

Background. Anticarcinoembryonic (CEA) monoclonal antibodies are able to react specifically with the antigen and have the potential for the detection of CEA‐bearing tumors. Methods. The authors photoscanned with indium 111 (111In)‐labeled F(ab)2 fragments of the murine CEA monoclonal antibody F023C5 63 patients with a newly diagnosed and pathologically documented bronchogenic carcinoma. Planar dual views of the thorax, abdomen, and brain were acquired between the 24th and 144th hour after the radiotracer injection. Patients had a complete pretreatment workup, which included a routine multiorgan computed tomography (CT) scan, and the determination of the serum and tissue CEA concentration. All patients were followed up clinically and radiologically. Nineteen needle aspirations and biopsies, 23 surgical explorations, and 4 mediastinoscopic studies yielded 121 pathologically documented sites of reference. Results. Fifty‐seven of 63 scans were positive for the primary tumor (sensitivity, 0.90). The uptake of the radiotracer correlated significantly with the intensity of tissue CEA expression (Spearman R [R,], 0.25; P 0.05), but not with the serum CEA level or with the histotype. Overall, the sensitivity of the anti‐CEA immunoscintigraphy (IS) for the N1, N2, N3, T3, T4, and MI disease (1987 International Union Against Cancer [UICC] staging classification) was 0.67, 0.64, 0.62, 0.31, 0.29, and 0.86, respectively. Corresponding values of specificity were 0.67, 0.81, 0.90,1,1, and 0.93; accuracy values were 0.67, 0.71, 0.85, 0.71, 0.76, and 0.92. The authors limited the analysis to all of the pathologically documented sites and obtained slightly superior values but no meaningful differences. The stage derived from IS readings was correct in 33 patients. The same figure was obtained after an initial clinical workup, which included physical examination, laboratory routine tests, chest radiographs, bronchoscopy, and any diagnostic procedure indicated by those tests. Conclusions. Anti‐CEA F023C5‐F(ab)2 fragments are not yet “magic bullets” for perfect diagnoses; however, their staging potential seems to be remarkable. Technical improvements, single‐photo emission CT, and the use of such fragments in combination with other imaging techniques might enable researchers to further improve the current results. Cancer 1992; 70:749–759. Copyright © 1992 American Cancer Society